Product Information
QUETIAPINE ER 400 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3055 per EA under NDC 65862087760. Its NADAC has been published 389 times since Mar 14, 2018.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862087760
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA207655FDA Approved
11/29/2017
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 400 MG TABLET has been published 389 times since Mar 14, 2018, and over the history we have for it it has declined 70.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3055 per EA |
|---|---|
| All-time high | $1.0345 (Mar 14, 2018) |
| All-time low | $0.2506 (Jul 17, 2024) |
| Median price | $0.4700 |
| Average price | $0.5057 |
| Largest weekly change | +47.1% (Aug 21, 2024) |
| Weeks tracked | 389 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-35.8%
5Y
-42.4%
All
-70.5%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 400 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3055 per EA (NDC 65862087760), effective Aug 20, 2025.
How has the price of QUETIAPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 400 MG TABLET has declined 70.5%. It has been tracked across 389 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 400 MG TABLET?
Since Mar 14, 2018, the NADAC for QUETIAPINE ER 400 MG TABLET has ranged from a low of $0.2506 (Jul 17, 2024) to a high of $1.0345 (Mar 14, 2018), with a median of $0.4700 per EA.
Are there cheaper alternatives to QUETIAPINE ER 400 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 400 MG TAB, is $0.1548 per EA — about 49% below QUETIAPINE ER 400 MG TABLET.
Who manufactures QUETIAPINE ER 400 MG TABLET?
QUETIAPINE ER 400 MG TABLET (NDC 65862087760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.